Literature DB >> 22892237

Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs).

Daniel Holzinger1, Rudolf Seemann, Clemens Klug, Rolf Ewers, Gabriele Millesi, Arnulf Baumann, Arno Wutzl.   

Abstract

OBJECTIVES: Bisphosphonates are associated with osteonecrosis of the jaw. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) may be treated conservatively or by surgery. PATIENTS AND METHODS: 108 patients underwent surgery and 88 patients were followed for a mean period of 337 days. Age, gender, dental procedures, underlying disease, and the role of bisphosphonate treatment in the success of surgery were evaluated retrospectively.
RESULTS: Surgical treatment improved the stage distribution from 19% stage I, 56% stage II and 25% stage III to 59% intact mucosa, 19% stage I and 13% stage II and 8% stage III. The improvement in the stage of disease achieved by surgery was statistically significant. Further relevant parameters that favor a positive outcome of surgery were the event triggering the outbreak of BRONJ (p=0.05) and the underlying disease (p=0.05). BRONJ in the maxilla necessitated repeat surgery significantly earlier than did BRONJ in the mandible (p=0.03).
CONCLUSION: Effective surgery might improve the outcome of BRONJ, although prevention still is the most important aspect of this condition.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22892237     DOI: 10.1016/j.oraloncology.2012.07.008

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  13 in total

1.  Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw.

Authors:  Yoon Ho Kim; Ho Kyung Lee; Seung Il Song; Jeong Keun Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2014-10-24

2.  Conservative surgical treatment in the management of BRONJ: a case series of 129 consecutive cases.

Authors:  M Gabriele; F La Ferla; S Cei; M Nisi; F Graziani
Journal:  Ann Stomatol (Roma)       Date:  2013-10-24

3.  Antiresorptive therapy and dental implant survival: an up to 20-year retrospective cohort study in women.

Authors:  Yu-Chi Cheng; Rolf Ewers; Katherine Morgan; Muneki Hirayama; Laura Murcko; John Morgan; Edmara T P Bergamo; Estevam A Bonfante
Journal:  Clin Oral Investig       Date:  2022-08-24       Impact factor: 3.606

Review 4.  Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.

Authors:  Larissa Fernandes Silva; Cláudia Curra; Marcelo Salles Munerato; Carlos Cesar Deantoni; Mariza Akemi Matsumoto; Camila Lopes Cardoso; Marcos Martins Curi
Journal:  Oral Maxillofac Surg       Date:  2015-12-11

5.  Relevance of surgical management of patients affected by bisphosphonate-associated osteonecrosis of the jaws. A prospective clinical and radiological study.

Authors:  Philippe Lesclous; Sophie Grabar; Semaan Abi Najm; Jean-Pierre Carrel; Tommaso Lombardi; Jean-Louis Saffar; Jacky Samson
Journal:  Clin Oral Investig       Date:  2013-04-19       Impact factor: 3.573

Review 6.  Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment.

Authors:  Lars Rasmusson; Jahan Abtahi
Journal:  Int J Dent       Date:  2014-09-01

7.  The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection.

Authors:  Guenter Russmueller; Rudolf Seemann; Kathrin Weiss; Victoria Stadler; Manuel Speiss; Christos Perisanidis; Thorsten Fuereder; Birgit Willinger; Irene Sulzbacher; Christoph Steininger
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

8.  Bisphosphonate-related osteonecrosis of the jaw in metastatic breast cancer patients: a review of 25 cases.

Authors:  Hong-Joon Kim; Tae-Jun Park; Kang-Min Ahn
Journal:  Maxillofac Plast Reconstr Surg       Date:  2016-02-01

Review 9.  Analysis of different therapeutic protocols for osteonecrosis of the jaw associated with oral and intravenous bisphosphonates.

Authors:  E-B Bermúdez-Bejarano; M-Á Serrera-Figallo; A Gutiérrez-Corrales; M-M Romero-Ruiz; R Castillo-de-Oyagüe; J-L Gutiérrez-Pérez; G Machuca-Portillo; D Torres-Lagares
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-01-01

10.  Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma.

Authors:  Svetlana Krstevska; Sonja Genadieva Stavric; Lidija Cevrevska; Borce Georgjievski; Oliver Karanfilski; Tatjana Sotirova; Trajan Balkanov
Journal:  Med Arch       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.